This Invitation to Offer (ITO) is for the supply of Closed System Transfer Devices (CSTD) for Metro North Hospital and Health Service (MNHHS). The objective is to establish a contract for CSTD that prevent environmental contaminants and pharmaceutical exposure. The tender process includes a mandatory pass/fail stage for ARTG certification, ISO compliance, NIOSH definition adherence, and sterile component requirements. Desirable criteria focus on quantified residual volume, product compatibility, user-friendliness, and transition plans. Offers must be submitted electronically via VendorPanel by May 8, 2026. No briefing sessions or site visits will be held.
The bid notice states that offers must be lodged by the closing date and time, which is 5:00 PM Queensland time on Friday 8th May 2026.
The evaluation process for this tender will include four stages: mandatory pass/fail, desirable criteria, clinical trial, and price.
To be a conforming offer, the offer must be received by the closing date and time, be received in the format and method described in this ITO, be open for the minimum offer validity period, satisfy all mandatory evaluation criteria, and respond to all applicable sections of Part C ITO response schedules, pricing schedule and addendas in full and provide relevant attachments.
MNHHS will not be holding site visits for this opportunity.
Samples will be requested from shortlisted suppliers for a functional assessment by the evaluation panel.
The closing date for information clarification questions is 5:00 PM Queensland time 3 business days prior to the closing date and time of this invitation to offer, which is 5th May 2026.